...
首页> 外文期刊>Neuron >BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders
【24h】

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

机译:BrainSeq:神经基因组学驱动神经精神疾病的新型靶标发现

获取原文
获取原文并翻译 | 示例
           

摘要

We outline an ambitious project to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmaceutical companies and a not-forprofit medical research institution working as a precompetitive team to generate and analyze publicly available archival brain genomic data related to neuropsychiatric illness.
机译:我们概述了一个雄心勃勃的项目,以表征人类主要生命在精神疾病和对照样本中不同大脑区域中转录的多个方面的遗传和表观遗传学调控。最初专注于精神分裂症和情绪障碍,该财团的目标是阐明遗传关联的潜在分子机制,以鉴定新的治疗靶标。该财团目前由七家制药公司和一家非营利性医学研究机构组成,该研究机构作为竞争前的团队工作,以生成和分析与神经精神疾病有关的公开可用的档案大脑基因组数据。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号